Imaging trial with SAR-Bombesin in prostate cancer opens for recruitment in Australia
Sydney, Australia 22 August 2022 Highlights Diagnostic investigator-initiated trial (IIT) with one of Clarity’ core products, SAR-Bombesin, commenced at St Vincent’s Hospital Sydney, led by Prof Louise Emmett. The Phase II IIT builds on the data generated in PSMA-negative prostate cancer patients at St Vincent’s Hospital imaged under the Therapeutic Goods Administration (TGA) Special Access…